- Much of the trust in a Singapore healthcare brand comes from Singapore’s regulatory system: provider licensing, advertising rules and, from early 2027, the National Electronic Health Record.
- Most of these guarantees stay in Singapore, so a provider entering a new market in the region has to supply its own.
- The largest Singapore deals in Vietnam bought accredited local hospitals and kept their local names.
- The Underwriting Test (Exhibit 1) lists each claim a provider makes, its guarantor at home and the commitment the brand must fund abroad. Boards can price these commitments before a deal closes.
Regulators underwrite most of what a healthcare brand promises
A healthcare brand makes promises that patients cannot check for themselves. Patients cannot audit a surgeon’s competence, a clinic’s hygiene or a provider’s handling of their data. They rely on an institution that can, such as a regulator, a professional register or an advertising rule. We call this institution the underwriter. It makes a brand’s claim believable without asking the patient to take the brand’s word for it.
Branding alone cannot do this work. A logo, a tagline or a well-designed reception can point to a guarantee, but the guarantee itself sits with the underwriter. Our article on healthcare brand trust explains how providers build trust in a regulated market.
Boards often value a healthcare brand as though the organisation earned all of its trust. In practice, the regulatory system supplied a large share of it.
Singapore’s regulators lend credibility to every provider they license
A Singapore patient who reads a clinic’s description of a treatment relies on two safeguards, often without noticing them. The clinic is licensed under the Healthcare Services Act. Its advertising must comply with the Healthcare Services (Advertisement) Regulations 2021. According to MOH’s guidance, these regulations stop licensees’ advertisements from creating unrealistic expectations or encouraging unnecessary use of care. Patients benefit from the rules without knowing their names, because every claim they see has already passed through them.
The effect resembles a co-signed loan. A borrower with a short credit history secures a good rate because a stronger guarantor signs alongside. At a bank that does not know the guarantor, the borrower is assessed on their own record. A Singapore provider in a new market is in the same position.
In a new market, patients judge a Singapore provider on its own record, without Singapore’s guarantees behind it.
The Health Information Act will widen the gap between home and abroad
Singapore is adding guarantees, and this raises the stakes for expansion. Parliament passed the Health Information Bill on 12 January 2026. MOH intends the Act to take effect from early 2027, according to the Ministry of Health. From then, licensed providers must contribute key patient information to the National Electronic Health Record. Our article on healthcare brand trust covers the Act’s effect on competition inside Singapore.
For a provider looking outward, the implication is direct. From 2027, the state will keep the promise "your records follow you" on behalf of Singapore providers. Most neighbouring markets have no equivalent national record. As Singapore’s system becomes more complete, the gap grows between a Singapore brand’s promises at home and its promises in Vietnam or Indonesia.
The gap concerns who guarantees a claim. It says nothing about the quality of care elsewhere. Private provision is well established across the region. Private for-profit care accounts for 53 per cent of the US$420 billion healthcare market across ASEAN member states. The figure comes from Think Global Health, a publication of the Council on Foreign Relations. The same analysis identifies information asymmetry as a persistent feature of private healthcare in the region. It also finds that patients in more paternalistic cultures are less likely to question their doctors. When patients question less and regulators guarantee less, the brand carries more of the responsibility.
Recent acquisitions show buyers paying for local licences and local names
The largest Singapore moves into the region bought hospitals with local licences, local reputations and international accreditation.
Thomson Medical Group acquired FV Hospital in Ho Chi Minh City for more than 9,000 billion VND, or US$381.4 million. FV Hospital describes the deal as the largest healthcare M&A transaction in Vietnam’s history. FV opened in 2003 as Vietnam’s first fully foreign-invested hospital. It was also the first hospital in southern Vietnam to earn Joint Commission International (JCI) accreditation. Its management team stayed on after the acquisition, and the hospital still trades as FV, with the Thomson name added alongside.
In October 2023, Raffles Medical Group announced it was taking a majority interest in American International Hospital in Ho Chi Minh City. The hospital was already JCI-accredited and known under its own name, and Raffles entered through a management agreement, as reported by Vietnam Investment Review. The group’s executive chairman spoke of offering "our unique brand of Raffles care" to patients in the region.
Both buyers made a rational choice. Their decisions show three assets experienced acquirers value: an established local licence, a local reputation and accreditation that travels. A Singapore name entering the market alone has to build that trust from the start.
Exhibit 1: The Underwriting Test, four questions that separate a brand’s claims from its guarantors
The Underwriting Test lists each claim a provider makes, the institution that makes it credible in Singapore, whether that institution operates in the target market, and the commitment the brand must supply in its place.
| The claim | The underwriter in Singapore | Does it operate in the target market? | What the brand must supply instead |
|---|---|---|---|
| "Safe, high standards of care" | MOH licensing under the Healthcare Services Act, with inspection and enforcement | Partly. A local licensing regime exists, but patients may not give it the same weight. | Published clinical governance: a named medical director, stated protocols and outcomes the provider chooses to disclose. |
| "What we tell you is accurate" | The Healthcare Services (Advertisement) Regulations 2021, which restrict unrealistic claims and testimonials | No. The Singapore rules stay in Singapore. | A voluntary claims standard that the brand publishes and visibly keeps. |
| "Your records follow you" | The National Electronic Health Record, mandatory for licensed providers from early 2027 under the Health Information Act | No equivalent national record in most target markets. | A stated records commitment: the records a patient can request, in which language, and how quickly. |
| "World-class specialists" | Singapore Medical Council registration of the doctors concerned | No. Local registration applies. | Named clinicians, with the training, credentials and experience of each stated plainly. |
| "Internationally accredited" | JCI and similar accreditation bodies | Yes. Accreditation is one of the few underwriters that travels. | A plain-language explanation of the checks behind the accreditation and their value to patients. |
Each "no" or "partly" in the third column is a cost. The brand must fund, staff and demonstrate the commitment in the fourth column itself. Boards should include these commitments in the deal model.
Keeping the acquired hospital’s name preserves the trust it has earned
After an acquisition, many groups want to put the parent’s name on the building. Integration is a reasonable aim, but a rename can move risk in the wrong direction.
A hospital with two decades of local reputation holds trust that local patients gave it under local rules. A new parent name replaces that proven guarantee with one those patients cannot yet assess. Thomson and Raffles both kept the acquired hospital’s own name in front, and so kept the trust it had earned.
A rename makes sense in three cases: when the acquired name carries damage, when patients are choosing the parent’s standards, or when a network needs one referral identity across several markets. Our analysis of institutional renaming sets out the general rule. A name should change when the organisation behind it has changed, and a change of ownership alone does not meet that test. Healthcare applies the rule more strictly, because the name stands for a promise about patients’ health.
Exhibit 2: What accreditation signals, and to whom
Accreditation is the one underwriter that crosses borders, so expanding providers rely on it heavily. Its meaning differs by audience.
| Audience | What accreditation tells them | What the brand still has to do |
|---|---|---|
| Insurers, referring doctors, corporate clients | A known, audited standard they can price and compare | Very little. They already recognise the signal. |
| Patients | Reassurance from an authority they may never have heard of | Explain it. Patients trust a seal once they understand the checks behind it. |
For professionals, an accreditation seal is a familiar signal. For patients, the brand has to explain it.
Providers build four commitments to replace the missing guarantees
Providers replace the missing guarantees with operating commitments, then communicate them clearly enough for patients to notice. Four commitments matter most:
- A published standard of conduct that sets out the claims the provider will and will not make, modelled on Singapore’s advertising rules.
- Named clinical leadership in the target market, so that "our specialists" refers to specific people.
- A records and privacy commitment written for patients, in place of the national record that does this work in Singapore.
- A naming and brand architecture decision based on evidence of the names local patients already trust.
These commitments apply specifically to licensed healthcare providers. Healthcare is the sector where a gap between a claim and its guarantee causes the most harm.
On cost and funding, most Singapore branding programmes fall between S$5,000 and S$50,000, with enterprise work higher. Singapore’s grant schemes have historically supported brand work tied to overseas expansion, and our guide to branding grants in Singapore sets out the current position.
Vietnam and Indonesia show the pattern most clearly
Vietnam shows the pattern most clearly, because the largest Singapore acquisitions have landed there. FV reports that around a quarter of its patients are foreigners living and working in Vietnam. Before FV opened, many of them flew to Singapore or Thailand for treatment. For these patients, a Singapore connection may add reassurance. The other three quarters know FV by its local name and local record.
Indonesia raises the same question at a larger scale. Think Global Health observes that the private sector there has filled gaps the state could not reach across the archipelago. In both markets, a Singapore provider meets patients who already trust local names and who are culturally less inclined to question a doctor. Self-imposed standards therefore matter more, because fewer external checks exist to catch an overstated claim. Our article on why Southeast Asian brands struggle to scale covers the general scaling challenge. In healthcare, the element that most often fails to scale is the guarantee.
Run the Underwriting Test before the deal closes
Run the Underwriting Test whenever a provider will make claims in a market that does not underwrite them. Typical triggers are a board approving a regional acquisition, a management team planning a greenfield clinic abroad, a post-merger decision on naming, and a first cross-border referral partnership.
The best time is before the deal closes, while the fourth column can still be priced. After closing, the same commitments appear as unbudgeted costs and slower patient acquisition.
The test matters less for a clinic that serves only Singapore-referred patients who return home for their records and follow-up. In that case, Singapore’s underwriters may still do most of the work. Providers should confirm this with evidence before relying on it.
Related Vantage insights
For the sector foundations, start with healthcare branding. Our article on healthcare brand trust sets out how providers build trust under regulation in a single market, including the changes the Health Information Act brings. For the naming decision after an acquisition, see our analysis of institutional renaming. The general scaling challenge is covered in why Southeast Asian brands struggle to scale, and funding for expansion-related brand work in branding grants in Singapore.
About Vantage Branding
Vantage is a Singapore brand consultancy specialising in brand research, strategy, and identity design for ambitious organisations across Southeast Asia, with particular depth in healthcare, finance, government, and cultural-institution branding. Vantage builds fewer, stronger brands, pairing research rigour with senior craft across strategy, identity, experience and activation. PMC-certified, with EDGE grant support for overseas expansion. For a conversation about how we could help your brand, get in touch.